13035-19-3 | Piperidin-4-amine

Packsize	Purity	Availability	Price	Discounted Price
5g	95%	in stock	$19.00	$13.00
25g	95%	in stock	$85.00	$60.00

Description

• Catalog Number: AB66694
• Chemical Name: Piperidin-4-amine
• CAS Number: 13035-19-3
• Molecular Formula: C5H12N2
• Molecular Weight: 100.1622
• MDL Number: MFCD02179399
• SMILES: NC1CCNCC1

Computed Properties

• Complexity: 48
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• XLogP3: -0.6

Literature

• Preparation and spectral characterization of fluorescence probes based on 4-N,N-dimethylamino benzoic acid and sterically hindered amines.

  Journal of fluorescence 20120901

• Variation of the intercalating proline in artificial peptides mimicking the DNA binding and bending IHF protein.

  Amino acids 20120701

• Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy.

  Epilepsia 20120501

• Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses.

  Nature neuroscience 20120205

• Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study.

  Alimentary pharmacology & therapeutics 20120201

• Exploring Left-Hand-Side substitutions in the benzoxazinone series of 4-amino-piperidine bacterial type IIa topoisomerase inhibitors.

  Bioorganic & medicinal chemistry letters 20110915

• Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20110727

• Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.

  Journal of molecular graphics & modelling 20110201

• Oligo(4-aminopiperidine-4-carboxylic acid): an unusual basic oligopeptide with an acid-induced helical conformation.

  Journal of the American Chemical Society 20100929

• Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.

  Bioorganic & medicinal chemistry letters 20100801

• Evaluation of a 4-aminopiperidine replacement in several series of CCR5 antagonists.

  Bioorganic & medicinal chemistry letters 20100315

• Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt).

  Journal of medicinal chemistry 20100311

• Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids.

  Pharmaceutical research 20090701

• The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat.

  Neurotoxicology 20081101

• Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.

  Bioorganic & medicinal chemistry 20080815

• C101, a novel 4-amino-piperidine derivative selectively blocks N-type calcium channels.

  European journal of pharmacology 20080610

• Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.

  Journal of medicinal chemistry 20080410

• Palladium-mediated N-arylation of heterocyclic diamines: insights into the origin of an unusual chemoselectivity.

  The Journal of organic chemistry 20070316

• Opposing inward and outward conductances regulate rebound discharges in olfactory mitral cells.

  Journal of neurophysiology 20070301

• Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease.

  Journal of neurochemistry 20070101

• Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.

  Bioorganic & medicinal chemistry letters 20061015

• Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubility.

  Bioorganic & medicinal chemistry 20060401

• Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonists.

  Bioorganic & medicinal chemistry 20060401

• Potent 4-aminopiperidine based antimalarial agents.

  Bioorganic & medicinal chemistry letters 20050117

• Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.

  Journal of medicinal chemistry 20041118

• [The mechanisms of short-term forms of synaptic plasticity].

  Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20040801

• Facile synthesis of 4-substituted-4-aminopiperidine derivatives, the key building block of piperazine-based CCR5 antagonists.

  Bioorganic & medicinal chemistry letters 20040716

• Stereocontrolled dopamine receptor binding and subtype selectivity of clebopride analogues synthesized from aspartic acid.

  Bioorganic & medicinal chemistry letters 20031006

• 4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs.

  Bioorganic & medicinal chemistry letters 20030721

• New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.

  Journal of medicinal chemistry 20021107

• A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.

  Bioorganic & medicinal chemistry letters 20020916

• The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.

  European journal of medicinal chemistry 20020601

• 4-Aminopiperidine ureas as potent selective agonists of the human beta(3)-adrenergic receptor.

  Bioorganic & medicinal chemistry letters 20011217